Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Introduction: Recurrent pulmonary exacerbations lead to progressive lung damage in cystic fibrosis (CF). Inhaled medications (mucoactive agents and antibiotics) help prevent exacerbations, but objectively measured adherence is low. We investigated whether a multi-component (complex) self-management intervention to support adherence would reduce exacerbation rates over 12 months. Methods: Between October 2017 and May 2018, adults with CF (aged ≥16 years; 19 UK centres) were randomised to the intervention (data-logging nebulisers, a digital platform and behavioural change sessions with trained clinical interventionists) or usual care (data-logging nebulisers). Outcomes included pulmonary exacerbations (primary outcome), objectively measured adherence, body mass index (BMI), lung function (FEV 1) and Cystic Fibrosis Questionnaire-Revised (CFQ-R). Analyses were by intent to treat over 12 months. Results: Among intervention (n=304) and usual care (n=303) participants (51% female, median age 31 years), 88% completed 12-month follow-up. Mean exacerbation rate was 1.63/year with intervention and 1.77/year with usual care (adjusted ratio 0.96; 95% CI 0.83 to 1.12; p=0.64). Adjusted mean differences (95% CI) were in favour of the intervention versus usual care for objectively measured adherence (9.5% (8.6% to 10.4%)) and BMI (0.3 (0.1 to 0.6) kg/m 2), with no difference for %FEV 1(1.4 (−0.2 to 3.0)). Seven CFQ-R subscales showed no between-group difference, but treatment burden reduced for the intervention (3.9 (1.2 to 6.7) points). No intervention-related serious adverse events occurred. Conclusions: While pulmonary exacerbations and FEV 1 did not show statistically significant differences, the intervention achieved higher objectively measured adherence versus usual care. The adherence difference might be inadequate to influence exacerbations, though higher BMI and lower perceived CF treatment burden were observed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the adjusted data from the Wildman 2022 trial demonstrated a difference in favour of the CFHealthHub intervention on treatment burden at 12 months compared with usual care (MD 3.90, 95% CI 1.20 to 6.60; Analysis 1.21).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Wildman 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When measured objectively, using data-logging nebulisers, results from one large, 19-centre trial (607 participants) showed that a digital intervention (CFHealthHub) combined with behaviour change sessions with trained interventionists, can increase adherence to inhaled therapies in adults with CF by 18% (9.5% increase from baseline) at 12 months, compared with usual care (Wildman 2022).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Wildman 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Results did, however, show 18% more medication taken in the intervention group than the control group at the 'over six months and up to 12 months' time point (MD 18.00, 95% CI 12.90 to 23.10; Analysis 1.1) (Wildman 2022).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Wildman 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The adjusted mean treatment burden score was 3.90 higher in the intervention group compared to usual care. MD 3.90 (1.20 to 6.60) 539 participants (1 study) low b,d”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Wildman 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Only one trial found a difference between groups in one domain of the CFQ-R (treatment burden) at this time point, SMD 0.26 (95% CI 0.09 to 0.43; Analysis 1.20) (Wildman 2022).”
From Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (2023) · cites this paper as Wildman 2022
Experimental — accuracy not yet measured
40 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Michie, S., van Stralen, M. M., & West, R. (2011) · Implementation Science · doi:10.1186/1748-5908-6-42 · Cited by 13,697 · cited 1×
“16 Reflective motivation is largely dependent on perceived necessity of adherence and treatment concerns 17 and can be increased through education, persuasion and confidence building.”
Adherence to Long-Term Therapies: Evidence for Action
De Geest, S., & Sabaté, E. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,272
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Horne, R., Weinman, J., & Hankins, M. (1999) · Psychology & Health · doi:10.1080/08870449908407311 · Cited by 2,372 · cited 2×
“16 Reflective motivation is largely dependent on perceived necessity of adherence and treatment concerns 17 and can be increased through education, persuasion and confidence building.”
Horne, R., & Weinman, J. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00057-4 · Cited by 2,201 · cited 2×
“Developing strategies to increase adherence is another CF research priority(12) and could improve health outcomes by reducing exacerbation rates.(6) Insufficient evidence exists to promote any particular adherence strategy.”
BackgroundDevelopment and Testing of a Short Form of the Patient Activation Measure
Hibbard, J. H., Mahoney, E. R., Stockard, J., & Tusler, M. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.00438.x · Cited by 1,935 · cited 6×
“Robust adherence data allowed us to demonstrate a sustained adherence difference for 12 months, which is the first for inhaled medications in any LTC. Sustained objectively measured adherence benefits for behavioural interventions in other LTCs are limited to two studies, both for oral medications among older adults i…”
InfluentialGardner, B. (2015) · Health Psychology Review · doi:10.1080/17437199.2013.876238 · Cited by 1,016 · cited 2×
“18 19 Literature in LTCs emphasises that sustained adherence is generally more strongly associated with habit than reflective motivation, which is more effortful.”
ECFS best practice guidelines: the 2018 revision
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.006 · Cited by 765
Contamination in trials: is cluster randomisation the answer?
Torgerson, D. J. (2001) · BMJ · doi:10.1136/bmj.322.7282.355 · Cited by 508
High treatment burden in adults with cystic fibrosis: challenges to disease self-management
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.007 · Cited by 498
Cited by
Standards for the care of people with cystic fibrosis; establishing and maintaining health
Southern, K. W., Addy, C., Bell, S. C., Bevan, A., Borawska-Kowalczyk, U., Brown, C., Burgel, P., Button, B., Castellani, C., Chansard, A., et al. (2023) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2023.12.002 · Cited by 124
“Remote monitoring can supplement face to face care at CF centres to assist early detection of clinical decline [151] and to support adherence [152].”
InfluentialDeveloping learning health systems in the UK: Priorities for action
Hardie, T., Horton, T., Thornton-Lee, N., Home, J., & Pereira, P. (2022) · doi:10.37829/hf-2022-i06 · Cited by 49
An integrated early care pathway for autism
Green, J., Leadbitter, K., Ainsworth, J. D., & Bucci, S. (2022) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(22)00037-2 · Cited by 50
Self-citationRobinson, L., Arden, M. A., Dawson, S., Walters, S. J., Wildman, M. J., & Stevenson, M. (2022) · Health Psychology Review · doi:10.1080/17437199.2022.2034516 · Cited by 33
“Findings from all six of these interventions showed positive e ff ects on adherence (100%, 95%CI = [61 – 100%], p = 0.03), but e ff ect sizes ranged from small (RR = 1.03, Tang et al., 2014) to very large (adjusted d = 1.71, Wildman et al., 2021; see Table 2).”
BackgroundMethodResultInfluentialSelf-citationMedication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review
Hansen, C. M. E., Breukelman, A. J., van den Bemt, P. M. L. A., Zwitserloot, A. M., van Dijk, L., & van Boven, J. F. M. (2024) · European Respiratory Review · doi:10.1183/16000617.0060-2024 · Cited by 31
“Furthermore, when adherence can be objectively measured, the next step is to develop interventions to improve adherence, possibly also supported by digital adherence technologies [43].”
Metadata
- Authors
- Wildman, M. J., O’Cathain, A., Maguire, C., Arden, M. A., Hutchings, M., Bradley, J., Walters, S. J., Whelan, P., Ainsworth, J., Buchan, I., Mandefield, L., Sutton, L., Tappenden, P., Elliott, R. A., Hoo, Z. H., Drabble, S. J., & Beever, D.
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Sheffield (GB)
- Sheffield Hallam University (GB)
- Queen's University Belfast (GB)
- University of Manchester (GB)
- University of Liverpool (GB)
- Corresponding author
- Wildman, Martin J
- ORCID
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2021-09-23
- Volume
- 77
- Issue
- 5
- Pages
- 461-469
- ISSN
- 0040-6376 (ISSN-L)
- 1468-3296
- PMC
- PMC9016257
- OpenAlex
- W3198550711
- Cited by
- 54
- References
- 46
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 15 · 2021: 4
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Thorax (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Research Explorer (The University of Manchester) (acceptedVersion, cc-by)
- SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) (acceptedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- PEARL (University of Plymouth) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
- Science and Technology Facilities Council (submittedVersion, cc-by)
- Funders
- Programme Grants for Applied Research (RP-PG-1212-20015)
- NHS England Commissioning for Quality and Innovation (IM2 Cystic Fibrosis Patient Adherence)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- cystic fibrosis, pulmonary exacerbations, medication adherence, self-management interventions, digital health platforms, behaviour change interventions, mucoactive agents, antibiotics, body mass index, lung function, treatment burden
- MeSH terms
- Self-Management, Treatment Adherence and Compliance, Adult, Cystic Fibrosis, Female, Humans, Lung, Male, Quality of Life, Respiratory Function Tests
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial. https://app.cochat.ai/papers/10.1136/thoraxjnl-2021-217594
- The paper
- Wildman, M. J., O’Cathain, A., Maguire, C., Arden, M. A., Hutchings, M., Bradley, J., Walters, S. J., Whelan, P., Ainsworth, J., Buchan, I., Mandefield, L., Sutton, L., Tappenden, P., Elliott, R. A., Hoo, Z. H., Drabble, S. J., & Beever, D. (2022). Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial. Thorax. https://doi.org/10.1136/thoraxjnl-2021-217594
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.